Verification evidence is still being completed.
PDF / print export
Affibody
Solna, Sweden
- Verified lead
- David Bejker
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- President and CEO
- 2026 technical specialization
- Protein Engineering, Targeted Therapeutics, Molecular Imaging, Oncology, and Affibody Molecules
- Review cycle
- May 2026
- Full address
- Affibody Medical AB, Scheeles vag 2, SE-171 65 Solna, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Affibody governance page confirming the Solna address.
- Editorial note
- Affibody is published because official company materials confirm current leadership, Solna operating address, and a differentiated protein-therapeutics platform.
Protein Engineering, Targeted Therapeutics, Molecular Imaging, Oncology, and Affibody Molecules
Official leadership disclosure, Official Solna address disclosure, Therapeutics platform claim
Affibody is published because official company materials confirm current leadership, Solna operating address, and a differentiated protein-therapeutics platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Solna, Sweden
Affibody
Protein Engineering, Targeted Therapeutics, Molecular Imaging, Oncology, and Affibody Molecules · Development-stage therapeutics platform
Affibody runs protein therapeutics development, molecular imaging programs, and targeted oncology platform work in Solna, Sweden.
- Lead
- David Bejker (verified ↗)
- Address
- Affibody Medical AB, Scheeles vag 2, SE-171 65 Solna, Sweden (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Development-stage therapeutics platform
- Capabilities
- Protein Therapeutics Development · Molecular Imaging Programs · Targeted Oncology Platform Work
- Founded
- 1998
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
David Bejker
President and CEO
Full addressAffibody Medical AB, Scheeles vag 2, SE-171 65 Solna, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Development-stage therapeutics platform
Solna, Sweden. Protein Engineering, Targeted Therapeutics, Molecular Imaging, Oncology, and Affibody Molecules. Review completed on 21 Mar 2026.
Swedish corporate and therapeutics-development oversight
Official leadership disclosure, Official Solna address disclosure, Therapeutics platform claim
Protein Engineering, Targeted Therapeutics, Molecular Imaging, Oncology, and Affibody Molecules
Affibody is published because official company materials confirm current leadership, Solna operating address, and a differentiated protein-therapeutics platform.
Editorial note
Affibody is published because official company materials confirm current leadership, Solna operating address, and a differentiated protein-therapeutics platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Protein Therapeutics Development
Molecular Imaging Programs
Targeted Oncology Platform Work
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Protein-engineering workflow
Molecular-design systems
Therapeutics R&D infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Affibody located?
- Affibody operates from Affibody Medical AB, Scheeles vag 2, SE-171 65 Solna, Sweden, Solna, Sweden.
- Who runs Affibody?
- Affibody is led by David Bejker, President and CEO. Verified 21 Mar 2026.
- What does Affibody do?
- Affibody runs protein therapeutics development, molecular imaging programs, and targeted oncology platform work in Solna, Sweden. Core capabilities: Protein Therapeutics Development, Molecular Imaging Programs, Targeted Oncology Platform Work.
Editorial context
Related technical briefs
Briefs that name Solna as a covered market or city.